Co-led by Berkeley Catalyst Fund and Fulcrum Global Capital, the round included participation from Elanco Animal Health, Innovation in Motion, and Viking Global Investors. Resilient Biotics develops a discovery platform to assess the respiratory commensal microbiome and...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)